Novo Nordisk has joined forces with Amazon Web Services (AWS) on a project that will lead to the creation of an AI ...

The EU’s Joint Clinical Assessment (JCA), introduced 12th January 2025 under the EU Health Technology Assessment (HTA) ...

Thousand Oaks, California startup Latigo, trading under the LTGO ticker, also landed an impressive sum in its IPO, selling 19 ...

Under the terms of the deal, ‌Lantheus' shareholders will get $102.50 per share in cash when the deal closes, along with the ...

The National Medical Products Administration (NMPA) has cleared Yochanra (tinengotinib) for adult patients with unresectable ...

The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large ...

There is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb, according to ...

At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, giving the company its ...

Koray Kavukcuoglu, DeepMind's chief technology officer and Google's chief AI architect, is taking on the operational ...

Tarsus is paying $450 million upfront for Alkeus – made up of $270 million in cash and $180 million in stock – with another ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

Takeda's orexin agonist Orzeyful has been approved in the US to treat narcolepsy type 1 (NT1) in adults, becoming the first ...